Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
I have appreciated the support from my manager, leadership and team. The environment at KPTI is fast paced with opportunity to innovate and try new things - with a priority and focus on people and patients first.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Teamwork and support from my KPTI colleagues
Che cosa ti rende più felice sul posto di lavoro?
Being a resource and cross functional partner to my KPTI colleagues and leadership.
Quali sono alcune delle cose migliori della tuo team?
We are one team. Everyone supports each other regardless of their role or function. This allows us to achieve our goals and objectives.
Other Employee Reviews for Karyopharm Therapeutics
×